Supernus Pharmaceuticals
SUPN
#4382
Rank
S$3.54 B
Marketcap
S$61.03
Share price
-1.69%
Change (1 day)
52.30%
Change (1 year)

Supernus Pharmaceuticals (SUPN) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : S$0.54 Billion

According to Supernus Pharmaceuticals 's latest financial reports the company's total liabilities are S$0.54 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Supernus Pharmaceuticals - Total liabilities on balance sheet (from 2009 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31S$0.50 B11.11%
2024-12-31S$0.45 B-3.96%
2023-12-31S$0.47 B-57.02%
2022-12-31S$1.09 B-7.31%
2021-12-31S$1.18 B17.54%
2020-12-31S$1.00 B31.9%
2019-12-31S$0.76 B6.22%
2018-12-31S$0.71 B241.45%
2017-12-31S$0.20 B23.14%
2016-12-31S$0.17 B19.8%
2015-12-31S$0.14 B12.1%
2014-12-31S$0.12 B29.25%
2013-12-31S$98.23 M120.56%
2012-12-31S$44.53 M-22.35%
2011-12-31S$57.35 M-51.25%
2010-12-31S$0.11 B-2.62%
2009-12-31S$0.12 B0.71%
2008-12-31S$0.11 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
S$154.65 B 28,138.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$74.57 B 13,517.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$110.30 B 20,040.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$85.74 B 15,557.20%๐Ÿ‡บ๐Ÿ‡ธ USA
United Therapeutics
UTHR
S$1.05 B 91.81%๐Ÿ‡บ๐Ÿ‡ธ USA